Cypress Capital Management (Wyoming)’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$114K Hold
95
– – 0.1% 74
2026
Q1
$87.4K Hold
95
– – 0.08% 72
2025
Q4
$102K Sell
95
-3
-3% -$2.87K 0.09% 68
2025
Q3
$74.8K Sell
98
-13
-12% -$9.67K 0.07% 78
2025
Q2
$86.5K Buy
111
+29
+35% +$22.5K 0.09% 67
2025
Q1
$67.7K Hold
82
– – 0.08% 73
2024
Q4
$63.3K Hold
82
– – 0.07% 72
2024
Q3
$72.6K Hold
82
– – 0.08% 72
2024
Q2
$74.2K Sell
82
-3
-4% -$2.4K 0.08% 72
2024
Q1
$66.1K Hold
85
– – 0.07% 70
2023
Q4
$49.5K Sell
85
-15
-15% -$8.76K 0.05% 75
2023
Q3
$53.7K Hold
100
– – 0.06% 70
2023
Q2
$46.9K Hold
100
– – 0.05% 71
2023
Q1
$34.3K Hold
100
– – 0.04% 78
2022
Q4
$36.6K Hold
100
– – 0.05% 79
2022
Q3
$32K Hold
100
– – 0.05% 77
2022
Q2
$32K Buy
100
+75
+300% +$22.5K 0.04% 79
2022
Q1
$7K Hold
25
– – 0.01% 140
2021
Q4
$7K Hold
25
– – 0.01% 211
2021
Q3
$6K Hold
25
– – 0.01% 198
2021
Q2
$6K Hold
25
– – ﹤0.01% 251
2021
Q1
$5K Buy
+25
New +$4.89K ﹤0.01% 240
2019
Q3
– Sell
-20
Closed -$2K – 231
2019
Q2
$2K Hold
20
– – ﹤0.01% 240
2019
Q1
$3K Hold
20
– – ﹤0.01% 236
2018
Q4
$2K Buy
+20
New +$2.23K ﹤0.01% 298

Other funds holding LLY

Cypress Capital Management (Wyoming)'s LLY Position: Q2 2026 in Review

Cypress Capital Management (Wyoming) held its Eli Lilly (LLY) position steady in Q2 2026 at 95 shares worth $114K. The position accounts for 0.1% of the portfolio, ranked #74.

Cypress Capital Management (Wyoming) first reported a position in LLY in Q4 2018 and has held it in 25 quarters since. 4,642 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Cypress Capital Management (Wyoming) held 95 shares of Eli Lilly worth $114K as of Q2 2026.
  • Cypress Capital Management (Wyoming) left its Eli Lilly share count unchanged in Q2 2026.
  • Eli Lilly made up 0.1% of Cypress Capital Management (Wyoming)'s portfolio in Q2 2026, its #74 holding.
  • Cypress Capital Management (Wyoming) first reported a position in Eli Lilly in Q4 2018 and has held it in 25 quarters since.
  • 4,642 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Cypress Capital Management (Wyoming)'s 13F filing for Q2 2026, filed 6 Aug 2026.